NanoVir is a drug research company committed to the discovery of treatments for human papillomavirus or HPV using novel chemical and biological approaches to develop DNA-targeted therapies. By targeting HPV DNA rather than more traditional antiviral targets, the company has identified a series of compounds that dramatically reduce the viral DNA load of cells harboring the virus.
Dr. Chris Fisher
NanoVir,LLC. co-founder Dr. Chris Fisher is a cell and developmental biologist with extensive drug discovery experience. Prior to founding NanoVir, Dr. Fisher was a research advisor and senior scientist for Pharmacia Corporation, formerly The Upjohn Company. Within Pharmacia Dr. Fisher has played a leading role in key drug discovery projects charged with investigating and targeting the molecular machinery regulating cell division. Dr. Fisher also served on the faculty of the University of Washington School of Medicine where he was funded by the National Institutes of Health for studies of embryonic development and cell biology.
Among other works, Dr. Fisher is recognized as co- author of the "Hen's tooth" paper, a classic work in evolutionary biology. Dr. Fisher co-founded NanoVir with Dr. Bashkin in 2003.
For more information about this industry and Dr. Chris Fisher, (Click Here)
Dr. James Bashkin
NanoVir, LLC. co-founder Dr. James Bashkin is also research associate professor of chemistry and biochemistry at the University of Missouri, St. Louis where he also established a chemistry research group with funding from the National Institutes of Health and NanoVir, LLC. In addition to his research and corporate leadership within NanoVir, he is an international consultant, a member of the American Chemical Society and a member of the editorial advisory board for Chemical Reviews. Dr. Bashkin received his chemistry doctorate from Oxford University in 1982. He shared the Presidential Green Chemistry Challenge Award from President Clinton for his work in the area of "Green Chemistry" which was credited for setting the standard for pollution prevention in the automobile tire industry. Dr. Bashkin held positions at Washington University, Monsanto, and Pfizer prior to founding NanoVir with Dr. Fisher in 2003.
Photo credit to August Jenewein